Case Reports
Every UPC, EPO and national court decision our fee earners have written up — now filterable by the same 40+ tags they already use to classify each report, plus the court and industry sector behind it.
Does an ongoing phase 3 clinical trial and its published protocol suggest that the tested drug will be successful?
Summary A recent EPO Boards of Appeal decision, T 0136/24, has examined the issue of "reasonable expectation of success" when the prior art discloses a protocol to an ongoing phase 3 clinical trial.
Edwards v Meril – The Interaction of Parallel UPC and EPO Proceedings
What happens when a European Patent Office opposition is pending at the same time as a UPC action? And what happens if the EPO and UPC reach differing conclusions on the validity?
Brussels LD Grants Evidence Preservation and Inspection Order in Pertuzumab Biosimilar Dispute
Genentech Inc. & F. Hoffmann – La Roche AG v Organon & Co, Organon Heist B.V. NV Organon & Shanghai Henlius Biotech Inc. (UPC_CFI_407/2025 and 408/2025) Orders dated 30 May 2025 (ORD_23125/2025 and...
Clear all filters
The UPC Newsletter
Get expert insights and the top patent stories delivered straight to your inbox.